DOWN BALLOT — The Forward Majority super PAC has surged its planned spending to $45 million to elect Democrats to statehouses ...

The pair boast the two biggest candidates in the market, with NovoNordisk’s Wegovy/Ozempic (semaglutide) expected to make ...

Nate Cohn and his colleagues have published the first high-quality survey since KAMALA HARRIS replaced President JOE BIDEN on the ticket that suggests the VP’s hot streak may be coming to an end. The ...

Novo Nordisk today announced headline results from a phase 2a clinical trial with monlunabant, a small molecule oral ...

Bagsværd, Denmark, 16 September 2024 – On 7 August 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament ...

Diabetes medication shortages are nothing new. The most recent example concerns NovoNordisk’s drug Ozempic, originally designed to help the pancreas make more insulin but gained meteoric popularity ...

The company noted that Wegovy is the first obesity medication to receive a positive opinion recommending a label update that reflects reduced symptoms and improved physical limitations and exercise ...

Novo Nordisk expects to repurchase B shares for an amount up to DKK 20 billion during a 12-month period beginning 6 February 2024. As of 13 September 2024, Novo Nordisk has since 6 February 2024 ...

The Federal Trade Commission (FTC) has filed a legal complaint accusing the 3 largest pharmacy benefit managers (PBMs) in the ...

Novo Nordisk Inc. was sued Friday by five former employees who say the pharmaceutical company mismanages its $2.3 billion ...

Novo Nordisk is paying $55 million upfront to secure rights to a cell therapy for heart failure developed by Japanese startup Heartseed. The Danish drugmaker has acquired exclusive rights outside ...